Peer-reviewed article

Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.

Expert opinion on investigational drugsFeb 21, 2022United States9 citationsDOI: 10.1080/13543784.2022.2035358

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinMDMAKetaminePTSD

Keywords

Posttraumatic Stress DisorderSynaptic ConnectivityPsychedelicsPsychedelic-assisted Therapy

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026

ArticlePsilocybin

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.

Zaretsky TG, Jagodnik KM, Barsic R +10

Europe PMC2024

ArticlePsilocybin

Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".

Schuman HDM, Mina R, Barkova S +3

Europe PMC2026